ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZurichEvlaBio AG
EvlaBio AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of EvlaBio AG is the development of therapeutics, particularly first-in-class therapeutics in the field of cardiovascular and cardio-renal diseases. The focus is on the development of therapeutic monoclonal antibodies (mAb) that target specific target molecules such as FGFR4/FGF23 to treat chronic kidney diseases (CKD).

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

EvlaBio AG

✓ Offered1
Anti-FGFR4 antibody therapy
Targeted anti-FGFR4 monoclonal antibody therapy for the treatment of left ventricular hypertrophy in chronic kidney disease; blocks FGF23-mediated FGFR4 signals and pathological cardiac remodeling.
Trust & reputation

ranQ Trust Score of EvlaBio AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

EvlaBio AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
EvlaBio AG scores 71.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.58.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
EvlaBio AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
EvlaBio AG scores 31.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.31.44%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

EvlaBio AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once EvlaBio AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

EvlaBio AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank EvlaBio AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of EvlaBio AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Seestrasse 352
8038 Zurich

At a glance

Legal form
Corporation
UID
CHE-351.033.709
Founded
2022 · 4 years
Last commercial register change
August 7, 2025
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    NS
    Neurimmune Subone AG
    Schlieren
    NA
    Neurimmune AG
    Schlieren
    EA
    evitria AG
    Fahrweid
    CR
    Charles River Laboratories Switzerland AG
    Hettlingen
    PA
    Philochem AG
    Otelfingen
    MA
    Mabylon AG
    Schlieren
    CA
    CDR-Life AG
    Horgen
    AB
    Araris Biotech AG
    Au Zh